[Effects of Logacer in patients with chronic brain ischemia and moderate cognitive impairment: results of non-interventional clinical observation].
V V ZakharovPublished in: Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova (2022)
The drug Logacer is characterized by high effectiveness and good tolerability in patients with CCI.